{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:31:15Z","timestamp":1790105475398,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3150,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ccr.2004.12.004","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T01:37:00Z","timestamp":1103679420000},"page":"547-552","source":"Crossref","is-referenced-by-count":75,"title":["Focus on myeloproliferative diseases and myelodysplastic syndromes"],"prefix":"10.1016","volume":"6","author":[{"given":"Richard A.","family":"Van Etten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2004.12.004_BIB1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1062","article-title":"Mutations in SBDS are associated with Shwachman-Diamond syndrome","volume":"33","author":"Boocock","year":"2003","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ccr.2004.12.004_BIB3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","article-title":"Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder","volume":"101","author":"Braun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2004.12.004_BIB4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI21716","article-title":"EVI1 induces myelodysplastic syndrome in mice","volume":"114","author":"Buonamici","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ccr.2004.12.004_BIB5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI20476","article-title":"Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease","volume":"113","author":"Chan","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ccr.2004.12.004_BIB6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(03)00108-9","article-title":"PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease","volume":"3","author":"Cools","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.12.004_BIB8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc970","article-title":"The Fanconi anaemia\/BRCA pathway","volume":"3","author":"D'Andrea","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2004.12.004_BIB10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood.V96.7.2317","article-title":"Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia","volume":"96","author":"Dale","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2004.12.004_BIB12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(02)00081-8","article-title":"Focus on acute leukemias","volume":"1","author":"Gilliland","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.12.004_BIB15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor \u03b2 to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.12.004_BIB16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.12.004_BIB17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB18","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2002-04-1010","article-title":"Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome\/acute myeloid leukemia","volume":"101","author":"Harada","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB20","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1182\/blood.V100.3.1068","article-title":"Overcoming STI571 resistance with the farnesyltransferase inhibitor SCH66336","volume":"100","author":"Hoover","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Hu","year":"2004","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ccr.2004.12.004_BIB22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia","volume":"349","author":"Hughes","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB24","doi-asserted-by":"crossref","unstructured":"Kantarjian, H.M., and Talpaz, M. eds. (2004). Chronic Myelogenous Leukemia. Hematol. Oncol. Clin. N. Am. 18, xv\u2013xvi.","DOI":"10.1016\/S0889-8588(04)00033-4"},{"key":"10.1016\/j.ccr.2004.12.004_BIB25","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB26","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2003-03-0885","article-title":"Clonal hematpoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB27","first-page":"7149","article-title":"Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571)","volume":"62","author":"La Rosee","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ccr.2004.12.004_BIB28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB29","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1093\/emboj\/19.17.4655","article-title":"Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia","volume":"19","author":"Lavau","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.ccr.2004.12.004_BIB30","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","article-title":"Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder","volume":"103","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB31","first-page":"184a","article-title":"Efficacy and safety of CC5013 for treatment of anemia in patients with myelodysplastic syndromes","volume":"102","author":"List","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB32","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/10428190410001723278","article-title":"Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib","volume":"45","author":"Loriaux","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ccr.2004.12.004_BIB33","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1073\/pnas.0400063101","article-title":"Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs","volume":"101","author":"Mohi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2004.12.004_BIB34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00062752-200211000-00006","article-title":"Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions","volume":"9","author":"Molldrem","year":"2002","journal-title":"Curr. Opin. Hematol"},{"key":"10.1016\/j.ccr.2004.12.004_BIB35","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB36","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB37","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0268-960X(97)90022-9","article-title":"Idiopathic myelofibrosis","volume":"11","author":"Reilly","year":"1997","journal-title":"Blood Rev"},{"key":"10.1016\/j.ccr.2004.12.004_BIB39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1535-6108(04)00053-4","article-title":"Distinct stem cell myeloproliferative\/T-lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations","volume":"5","author":"Roumiantsev","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.12.004_BIB40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","article-title":"Essential role for Gab2 in transformation by BCR\/ABL","volume":"1","author":"Sattler","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.12.004_BIB41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0092-8674(94)90307-7","article-title":"Chronic myelomonocytic leukemia","volume":"77","author":"Sawyers","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.12.004_BIB42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.12.004_BIB43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","article-title":"Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders","volume":"336","author":"Side","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ccr.2004.12.004_BIB44","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","article-title":"Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome","volume":"20","author":"Silverman","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.ccr.2004.12.004_BIB45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ccr.2004.12.004_BIB47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodisplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ccr.2004.12.004_BIB48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00062752-200401000-00007","article-title":"SHP-2 and myeloid malignancies","volume":"11","author":"Tartaglia","year":"2004","journal-title":"Curr. Opin. Hematol"},{"key":"10.1016\/j.ccr.2004.12.004_BIB49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(01)90133-7","article-title":"Chronic myeloid disorders","volume":"38","author":"Tefferi","year":"2001","journal-title":"Semin. Hematol"},{"key":"10.1016\/j.ccr.2004.12.004_BIB50","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB51","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.12.004_BIB52","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804003411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804003411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T21:38:38Z","timestamp":1586036318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610804003411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1535610804003411"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2004.12.004","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}